SCHEMBL2446843

SCHEMBL2446843

O=C(CN1CCc2nc3ccccc3c(C(=O)N3CCN(CCO)CC3)c2C1)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.46
▸ LMNA P02545 6/20 0.46
▸ MAPT P10636 6/20 0.46
▸ HTT P42858 3/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ MAPK1 P28482 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2321274 0.94 MAPT (0.47) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2323215 0.93 ALDH1A1 (0.45) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2316096 0.91 MAPT (0.54) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL3350814 0.91 LMNA (0.46) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2448599 0.90 ALDH1A1 (0.53) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2319410 0.89 LMNA (0.47) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2445767 0.89 ALDH1A1 (0.41) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2320065 0.88 ALDH1A1 (0.46) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2443415 0.86 MAPT (0.40) ALDH1A1LMNAMAPTHTTNPSR1
SCHEMBL2316929 0.85 ALDH1A1 (0.46) ALDH1A1LMNAMAPTHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US claimed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN ENPP2, TPX2, TPD52L2 ALDH1A1 4584/4885LMNA 579/4885MAPT 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback